Companion Diagnostics
Various metabolic & renal drug candidates
Discovery/DevelopmentActive
Key Facts
Indication
Various metabolic & renal drug candidates
Phase
Discovery/Development
Status
Active
Company
About numares
Numares AG is a pioneering diagnostics company leveraging a unique combination of NMR spectroscopy and artificial intelligence to analyze blood metabolites. Its core technology, the AXINON® platform, is designed to identify complex disease signatures, moving beyond single biomarkers to enable earlier and more accurate diagnosis of conditions like chronic kidney disease and cardiovascular disorders. As a private company, Numares has progressed key assays through regulatory pathways, positioning itself in the high-growth precision diagnostics market. Its strategy involves both developing its own diagnostic tests and partnering with pharmaceutical companies for companion diagnostics.
View full company profile